ORSI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 1.122
AS - Asia 835
NA - Nord America 736
SA - Sud America 157
AF - Africa 17
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.876
Nazione #
US - Stati Uniti d'America 703
RU - Federazione Russa 669
SG - Singapore 289
CN - Cina 264
IT - Italia 175
BR - Brasile 129
HK - Hong Kong 106
VN - Vietnam 83
DE - Germania 52
FR - Francia 43
SE - Svezia 43
GB - Regno Unito 39
IN - India 30
NL - Olanda 21
CA - Canada 19
FI - Finlandia 17
PL - Polonia 16
AR - Argentina 15
ES - Italia 12
MX - Messico 12
JP - Giappone 10
ZA - Sudafrica 10
AT - Austria 8
AU - Australia 8
BD - Bangladesh 8
TR - Turchia 7
EC - Ecuador 5
IE - Irlanda 5
IQ - Iraq 5
KR - Corea 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
ID - Indonesia 4
AL - Albania 3
BE - Belgio 3
LT - Lituania 3
VE - Venezuela 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HR - Croazia 2
IR - Iran 2
MY - Malesia 2
PT - Portogallo 2
PY - Paraguay 2
TW - Taiwan 2
UA - Ucraina 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MV - Maldive 1
NG - Nigeria 1
QA - Qatar 1
SA - Arabia Saudita 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 2.876
Città #
Singapore 189
Moscow 149
Dallas 128
Ashburn 109
Hong Kong 103
San Jose 80
Beijing 53
Shanghai 44
Milan 40
Boardman 36
Hefei 31
Lauterbourg 30
New York 30
Los Angeles 28
Ho Chi Minh City 25
Hanoi 21
Warsaw 16
Cesano Boscone 14
Orem 12
Santa Clara 12
Council Bluffs 11
Amsterdam 10
Nuremberg 10
Stockholm 10
São Paulo 10
Chicago 9
Helsinki 9
London 9
Munich 9
Phoenix 9
Rome 9
Brooklyn 8
Chennai 8
Frankfurt am Main 8
Mexico City 8
Tokyo 8
Boston 7
Brescia 7
Lawrence 7
Montreal 7
Princeton 7
Rio de Janeiro 7
Seattle 7
Denver 6
Falkenstein 6
Hyderabad 6
Johannesburg 6
Manchester 6
Mumbai 6
Naples 6
Sydney 6
Atlanta 5
Bologna 5
Carlsbad 5
Houston 5
Lappeenranta 5
Vienna 5
Brasília 4
Buffalo 4
Campinas 4
Dublin 4
Guangzhou 4
Haiphong 4
Pisa 4
San Francisco 4
The Dalles 4
Turin 4
Baton Rouge 3
Bellpuig 3
Brussels 3
Da Nang 3
Dhaka 3
Essen 3
Fortaleza 3
Fuzhou 3
Mezzolombardo 3
Milton Keynes 3
New Delhi 3
Ottawa 3
Poplar 3
Porto Alegre 3
Querétaro 3
Romagnano Sesia 3
Seocho-gu 3
Thái Nguyên 3
Toronto 3
Turku 3
Würzburg 3
Ankara 2
Annapolis 2
Bagé 2
Baie-D'Urfé 2
Barnet 2
Belo Horizonte 2
Berlin 2
Bexley 2
Bollate 2
Bolzano 2
Brisbane 2
Bắc Giang 2
Totale 1.549
Nome #
ANALYSIS OF THE ACTIVITY OF NOVEL RADIOSENSITIZERS AND SYSTEMIC TREATMENTS IN PANCREATIC ADENOCARCINOMA: A ROAD MAP TO IMPROVE THE OUTCOME IN LOCALLY ADVANCED DISEASE. 156
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 140
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 129
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants 117
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 113
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 110
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 98
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 96
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 94
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 91
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 91
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease 87
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 87
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 86
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 86
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 85
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 84
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey. 82
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 81
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 81
The impact of nutritional status on pancreatic cancer therapy 79
Lessons and open questions in borderline resectable pancreatic cancer 77
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 74
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 73
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) 72
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 63
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 63
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 60
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 57
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 54
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma 53
Pancreatic cancer: still a cold case? 52
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 46
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology 42
The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis 42
Long-term Outcomes of EUS-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over time. 29
Long-term Outcomes of endoscopic ultrasound-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over time 16
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life 10
Pancreatic adenocarcinoma nutritional-clinical index (PANCIN): A novel prognostic tool in advanced pancreatic cancer. 9
Totale 2.965
Categoria #
all - tutte 11.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202368 14 11 5 0 1 16 3 10 2 0 6 0
2023/2024157 12 9 12 31 15 18 5 15 4 10 5 21
2024/2025575 39 11 19 22 29 59 85 76 56 65 54 60
2025/20262.156 190 160 130 254 215 79 190 187 639 112 0 0
Totale 2.965